![Man ultramarathon runner in the mountains he trains at sunset](https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/0B4B1380-42EB-4FD5-9D7E2DBC603E79F8/webimage-C4875379-1478-416F-B03DF68FE3D8DBB5.png)
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
ORIGINAL RESEARCH article
Front. Microbiol.
Sec. Microbe and Virus Interactions with Plants
Volume 16 - 2025 | doi: 10.3389/fmicb.2025.1544521
The final, formatted version of the article will be published soon.
You have multiple emails registered with Frontiers:
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Fusarium wilt caused by Fusarium oxysporum f. sp. medicaginis (Fom) is an important disease affecting lucerne/alfalfa cultivations worldwide. Medicago sativa L. (lucerne) is one of the major legume crops in global forage industry. This study aimed to identify bacteria capable of biologically controlling the wilt pathogen through a comprehensive screening of bacterial isolates obtained from domesticated and wild growing Medicago seeds. Using a multi-tiered evaluation pipeline, including in vitro, soil-free and potting mix-based pathogenicity and bioprotection assay systems, the bioprotection efficacy of 34 bacterial isolates derived from Medicago seeds was initially evaluated against six Fusarium strains in vitro. Fusarium oxysporum (Fo) F5189, which has previously been characterized as a Fusarium oxysporum f. sp. medicaginis isolate causing Fusarium wilt in lucerne was selected for in planta assays. Lucerne cultivars Grazer and Sequel, representing susceptible and resistant genotypes were chosen to assess the disease progression. Pathogenicity and bioprotection time-course studies were conducted to understand the temporal dynamics of host-pathogen interactions and efficacy of the bioprotectants. The disease symptoms were scored using a disease rating index developed in this study. The results indicated variability in bioprotection efficacy across bacterial isolates, with some strains suppressing disease in both soil-free and potting mix-based systems. Paenibacillus sp. (Lu_MgY_007; NCBI: PQ756884) and Pseudomonas sp. (Lu_LA164_018; NCBI: PQ756887) were identified as promising bioprotectants against Fusarium wilt under tested growth conditions. The time-course studies highlighted the critical role of persistent biocontrol activity and precise timing of biocontrol application for achieving long-term disease suppression. Overall, the observed reduction in disease severity underscores the potential of these bioprotectants as sustainable strategies for managing Fusarium wilt in lucerne cultivars. However, comprehensive molecular-level analyses are warranted to elucidate the underlying pathogenicity and bioprotection mechanisms, offering valuable insights for the development of more precise and effective future biocontrol strategies in agricultural systems.
Keywords: Fusarium Wilt, Medicago seeds, lucerne, alfalfa, Pseudomonas sp., Paenibacillus sp., biocontrol, plant pathogens
Received: 13 Dec 2024; Accepted: 10 Feb 2025.
Copyright: © 2025 Herath Dissanayakalage, Kaur, Achari and Sawbridge. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Shenali Subodha Herath Dissanayakalage, AgriBio, La Trobe University, Melbourne, Australia
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
From Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.